Views: 0 Author: Site Editor Publish Time: 2026-07-09 Origin: Site
In the rapidly evolving landscape of medical device manufacturing, Liquid Silicone Rubber (LSR) has established itself as a material of choice for critical applications. From implantable devices to precision sealing components, LSR offers a unique combination of biocompatibility, chemical inertness, and design flexibility that few other materials can match.
But what makes LSR so special? How does it differ from other medical-grade materials? And what goes into producing a high-quality LSR component?
This comprehensive guide walks you through everything you need to know — from material selection and injection molding processes to mold design and production preparation.
Medical-grade LSR is a platinum-catalyzed, two-component liquid elastomer that cures through addition polymerization. Unlike thermoplastics, LSR is thermosetting — once cured, it cannot be remelted or reshaped.
Medical-grade LSR offers exceptional biocompatibility, passing both ISO 10993 and USP Class VI standards — the highest classification for materials intended for long-term implantation. It operates across an extraordinary temperature range from -55°C to +200°C, withstanding repeated steam sterilization without degradation. The material exhibits remarkable chemical inertness, containing no plasticizers or leachable additives, and resists attack from solvents, acids, and bases. Its low compression set ensures sealing integrity over extended periods, while hardness can be customized across a broad range from 10 to 80 Shore A.
To be considered "medical-grade," LSR must undergo rigorous testing. ISO 10993‑1 mandates biological evaluation covering cytotoxicity, sensitization, and irritation. USP Class VI represents the most stringent biological reactivity classification for plastics. Additionally, FDA 21 CFR Part 177.2600 provides clearance for rubber articles intended for repeated use.
Understanding LSR requires comparing it against alternatives like PVC, TPU, and HCR.
LSR leads in biocompatibility — it is the only material among common medical elastomers that is routinely approved for long-term implantation. PVC, while extremely cost-effective, carries risks from DEHP plasticizer migration, which has been linked to endocrine disruption. TPU offers superior tear strength and abrasion resistance, making it ideal for high-wear applications, but its long-term biocompatibility record is less established than LSR's. HCR (high-consistency rubber) shares LSR's silicone chemistry but lacks its processing precision due to compression molding's inherent limitations.
When it comes to processing, LSR's liquid injection molding (LIM) delivers unparalleled precision and complexity, though at higher capital investment. PVC and TPU are processed via conventional thermoplastic methods with moderate precision. HCR, processed through compression or transfer molding, offers the lowest precision but requires minimal equipment investment.
This is not just technical jargon — it has profound practical implications.
LSR is a thermoset material. Its curing mechanism is chemical cross‑linking, which is irreversible. During processing, the mold must be heated (typically to 170–200°C) while the barrel and runners are kept cool to prevent premature curing. The curing process takes time, resulting in longer cycle times than thermoplastics. Runner waste cannot be recycled, making cold runner systems essential for economic production.
Thermoplastics like TPE and TPU operate on a fundamentally different principle. Their solidification is purely physical and reversible — they melt when heated and solidify when cooled. During processing, the barrel is heated while the mold is cooled. Cycle times are shorter since only cooling (not chemical reaction) is required. Runner waste can be ground and reused, offering greater material efficiency at the cost of potential property degradation.
Aging behavior also diverges significantly. LSR gradually hardens over decades of service while maintaining surface integrity. Certain thermoplastic elastomers may become sticky or brittle as plasticizers and processing oils leach out over time.
LSR is processed via Liquid Injection Molding (LIM) , a specialized variant of injection molding with unique requirements.
The journey from raw material to finished product follows a carefully orchestrated sequence. First, the two liquid components — one containing platinum catalyst, the other containing crosslinker — are precisely metered in a 1:1 ratio and blended in a static mixer. This mixture is then injected into a mold where the barrel and cold runner are maintained at low temperature while the mold cavity is heated to 170–200°C. Within the heated cavity, cross‑linking occurs over a period of 10 to 90 seconds. After curing, the part is demolded using ejector pins or air assist. For implantable grades, post‑curing (secondary vulcanization) follows, typically lasting 2 to 4 hours at 150–200°C. Finally, every part undergoes thorough inspection and packaging.
This is where LSR differs most dramatically from thermoplastic molding. The critical concept is dual temperature control: the barrel and cold runner are maintained at cool temperatures (20–30°C) to prevent premature curing, while the mold cavity is heated to 170–200°C to trigger the cross‑linking reaction. A needle shut‑off nozzle prevents material drool and backflow during injection.
The cold runner system is perhaps the most distinctive feature of LSR molding. Material in the runner stays at ambient temperature and never cures, meaning it can be ejected with each cycle and reused repeatedly. This enables near-zero scrap production — a significant economic advantage given the high cost of medical-grade LSR.
Once injected into the hot mold cavity, the LSR undergoes vulcanization — the chemical cross‑linking that transforms liquid into solid elastomer. Typical curing times range from 10 seconds for thin-walled parts up to 90 seconds for thicker components. Thicker sections require longer cure times, generally adding 5–10 seconds per millimeter of wall thickness beyond the first millimeter.
Demolding presents unique challenges because cured LSR tends to adhere to metal surfaces. Special mold coatings, such as diamond-like carbon (DLC) or PTFE-based release layers, help overcome this. Ejector pins must be precisely designed — mushroom-shaped heads improve sealing and prevent flash.
For implantable medical devices, post‑curing is mandatory. This secondary vulcanization step removes any residual volatiles and stabilizes the material's physical properties, ensuring compliance with ISO 10993 extractables requirements.
Finally, every part undergoes dimensional inspection, visual defect screening, and functional testing to meet stringent medical quality standards.
LSR mold design is fundamentally different from thermoplastic molds. The core challenge lies in managing cold versus hot zones within the same tool.
In LSR molding, the mold itself is heated to 170–200°C, while the barrel is cooled to 20–30°C — exactly opposite to thermoplastic processing. The runner system must be a cold runner design, keeping material in the runner at ambient temperature while the cavity is heated. Venting requirements are far more critical in LSR because its low viscosity and fast fill speed trap air easily. Shrinkage is substantially higher — 2.5 to 4 percent compared to 0.5 to 2 percent for most thermoplastics — and is anisotropic, meaning it differs between flow and cross‑flow directions. Flash control requires extreme precision; gaps as small as 10 micrometers can allow LSR to seep through parting lines.
Parting Line and Flash Control
LSR's low viscosity is both a blessing and a curse. It flows into microscopic gaps, making flash a persistent challenge. The solution lies in ultra-precision machining of parting surfaces to achieve micron-level flatness. Parting lines should be strategically located on non-cosmetic surfaces. Small chamfers at the parting line help utilize LSR's elastomeric properties for cleaner separation during demolding.
Venting System
LSR fills cavities at extremely high speed, trapping air that causes bubbles, voids, or incomplete filling. Standard venting employs channels 1–3 millimeters wide with depths of only 0.004–0.005 millimeters — about one-twentieth the thickness of a human hair. For critical medical components, vacuum-assisted venting is the preferred approach, evacuating air from the cavity before injection. Advanced micro-structured vents created by electrical discharge machining (EDM) produce 3–6 micrometer-high features that function simultaneously as labyrinth seals and air evacuation channels.
Cold Runner System
This is the hallmark of LSR mold design. The runner area must remain cool — below 70°C — while the cavity is heated to 200°C. The thermal insulation between these zones is a significant engineering challenge, often achieved using titanium alloy (grade 3.7165) insulation plates due to their low thermal conductivity.
Runner design requires careful attention to gate dimensions — typically 0.2 to 0.5 millimeters in diameter — and symmetrical layout to ensure balanced filling. Importantly, gate and ejector pins must be positioned on opposite sides of the mold because the part will stick to the ejector side.
Thermal Management
Uniform mold temperature is essential for consistent curing. Heating is typically provided by cartridge heaters or oil temperature controllers, with thermocouples ensuring temperature uniformity across the cavity within ±2°C. The thermal separation between cold runner and hot cavity demands robust insulation — again, titanium alloy plates are the industry standard.
Shrinkage Compensation
LSR expands significantly in the hot mold and shrinks upon cooling. Total shrinkage ranges from 2.5 to 4 percent, varying by material grade and part geometry. Critically, shrinkage is anisotropic — flow direction shrinkage exceeds cross‑flow direction shrinkage. Factors influencing final shrinkage include mold temperature, demolding temperature, cavity pressure, and part wall thickness (thicker sections shrink less). Secondary vulcanization adds another 0.5 to 0.7 percent shrinkage. All these factors must be pre‑compensated in the mold cavity dimensions.
Demolding Design
Cured LSR stubbornly adheres to metal surfaces, and the part's flexibility complicates ejection. Common solutions include ejector pins (mushroom-shaped heads improve sealing), stripper plates, and air-assisted demolding. Special release coatings such as PTFE or nickel-based layers reduce friction and prevent sticking. Ejector pin clearance must be tightly controlled — excessive clearance allows flash, while insufficient clearance causes sticking.
The mold frame and plates typically use pre-hardened steel such as 1.2312, which offers good impact resistance. Cavities and cores require nitrided or heat-treated tool steel to maintain dimensional stability at 200°C. For highly filled or abrasive LSR grades, powder metallurgy steel (like 1.2379) delivers the necessary hardness and wear resistance. Transparent LSR components demand polished stainless steel cavities to achieve optical clarity. Finally, PTFE or nickel coatings on release surfaces reduce friction and improve demolding performance.
Opening the mold for production requires extensive preparation. Here's what happens before the first part is made.
The mold's journey begins with steel processing using CNC machining and EDM to achieve tolerances of ±0.005 millimeters. The runner system is precisely assembled, and cavities undergo mirror polishing to achieve surface roughness below 0.05 micrometers — essential for medical products where bacterial colonization must be minimized. PVD or diamond-like carbon coatings are applied to critical surfaces to prevent sticking and chemical interaction between silicone and metal.
Medical-grade molds must be installed in ISO Class 7 or Class 8 cleanrooms to prevent particle contamination. Following installation, all thermal systems are connected — cooling lines for the cold runner, heating systems (cartridge heaters or oil temperature controllers) for the cavity, and built-in vacuum venting.
Preheating is a crucial step. The mold is gradually raised to its operating temperature of 170–200°C, requiring 30 to 60 minutes to achieve uniform temperature distribution. Uneven heating leads to inconsistent curing and rejects.
Before mass production can begin, trial runs — typically designated T1, T2, and so on — validate processing parameters and part quality. Engineers systematically optimize injection pressure, injection speed, mold temperature, and curing time. Every sample part undergoes dimensional inspection, visual defect screening, and mechanical testing.
The primary concerns in LSR trials are bubble defects, flash formation, and cold runner performance — issues that stem from LSR's low viscosity and reactive nature. The heating focus is on mold temperature uniformity rather than cooling rate optimization. Environmental control is a hard requirement — LSR trials must be conducted in cleanrooms, unlike most thermoplastic trials. Finally, LSR trials may require secondary vulcanization testing to confirm extractables meet ISO 10993 limits.
After successful trial runs, a small batch of 500 to 2,000 pieces is produced. This final validation step confirms process stability and repeatability, establishes dimensional consistency (requiring a CpK of at least 1.33), and produces samples for customer functional testing and regulatory filing.
A common question is whether LSR can use a hot runner system. The short answer is no — not in the traditional sense.
Traditional hot runners maintain the melt at elevated temperatures to ensure flow. For LSR, this would trigger premature cross‑linking within the runner itself. The consequences are severe: clogged nozzles requiring extensive downtime for cleaning, and expensive material wasted because cured silicone cannot be recovered or recycled.
The cold runner system keeps the entire runner at cool temperatures — typically 20–30°C — preventing any curing before material enters the heated cavity. This approach achieves near-zero material waste, as the uncured runner material can be reused in subsequent cycles. The design requires precise thermal separation between the cold runner and the hot cavity, a significant engineering achievement.
Some suppliers are now offering locally heated gate tips — a hybrid approach where the main runner remains cool but the gate area is briefly heated to accelerate curing precisely at the gate. This reduces cycle time while avoiding the risks of a full hot runner. However, this is still fundamentally a cold runner system with localized heating, not a traditional hot runner.
One of the most exciting developments is conductive LSR for wearable medical devices. Elkem's SILBIONE™ LSR Select EC 70 offers electrical resistivity below 10 ohm-centimeters while passing ISO 10993 biocompatibility tests for cytotoxicity and skin sensitization. This enables single-material molding of ECG electrodes, flexible sensors, and prosthetic interfaces — eliminating secondary assembly steps and improving reliability.
LSR's low viscosity allows it to fill cavities with features as small as 0.1 millimeters and produce parts weighing less than 10 milligrams. This capability is enabling next-generation minimally invasive devices, microfluidic chips for lab-on-a-chip applications, and precision drug delivery systems.
Software tools like Moldex3D and SIGMASOFT now predict filling imbalance, trapped air, jetting, and uneven curing with accuracy within 3 percent of experimental values. This allows engineers to identify and correct problems before steel is cut, dramatically reducing development time and cost.
Modular mold designs using standardized frames with replaceable inserts reduce development cost and lead time for small-batch medical products. Low-energy flash-free molding — achieved through optimized parting line design and micro-venting — reduces clamping force requirements, lowering energy consumption and eliminating secondary deflashing operations. This aligns with the medical industry's growing focus on sustainable manufacturing practices.
Choose LSR when your device is implantable or has long-term patient contact, where the highest level of biocompatibility is non-negotiable. Choose it when repeated steam sterilization is required — LSR withstands hundreds of autoclave cycles without degradation. Choose it when low extractables and chemical inertness are critical, or when tight tolerances of ±0.02 millimeters are needed in a flexible component. Choose LSR when you need multi-functional integration — combining sealing, valving, and sensing functions in a single molded part.
Consider TPU or PVC for short-term, single-use devices where cost sensitivity is paramount. TPU is also the better choice when superior tear strength or abrasion resistance is the primary requirement. For low-volume production of simple geometries, HCR offers minimal capital investment. PVC remains an economical option for non-critical, short-term contact applications, though regulatory pressure on DEHP is increasing.
Medical-grade LSR injection molding is a precision engineering discipline that sits at the intersection of material science, mold engineering, and production control. It demands understanding of thermoset chemistry and biocompatibility requirements, mastery of cold runner systems and thermal management at micron-level precision, and rigorous production control in cleanroom environments with comprehensive process validation.
The investment in LSR technology — both in materials and equipment — is significant. But for applications demanding the highest levels of safety, precision, and long-term reliability, LSR remains the benchmark against which all other medical elastomers are measured.
As innovations in conductive LSR, micro-molding, and simulation-driven design continue to emerge, the capabilities of this remarkable material will only expand — enabling the next generation of smart, miniaturized, and connected medical devices that will transform patient care.
ISO 10993‑1:2018 provides the framework for biological evaluation of medical devices. The FDA Guidance on the Use of International Standard ISO 10993‑1 offers regulatory context for US submissions. USP-NF General Chapter <88> details the biological reactivity tests for plastics. The DuPont™ Liveo™ Healthcare Materials Processing Guide and WACKER SILICONES' technical literature provide practical processing insights. The EU Medical Device Regulation (MDR) 2017/745 establishes general safety and performance requirements for devices sold in Europe.
